Trials / Completed
CompletedNCT00647387
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The AMPLATZER Muscular VSD Occluder was approved by the US Food and Drug Administration (FDA) in September, 2007. This study is designed to further evaluate the safety and effectiveness in subjects implanted with the AMPLATZER Muscular VSD Occluder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) | Device |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2024-02-23
- Completion
- 2024-02-23
- First posted
- 2008-03-31
- Last updated
- 2025-02-11
- Results posted
- 2025-02-07
Locations
51 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00647387. Inclusion in this directory is not an endorsement.